Epiminds
Epiminds develops multi-agent AI systems to run marketing end-to-end.
Epiminds develops multi-agent AI systems to run marketing end-to-end.
Epiminds has raised $6.6M across 1 round. Its most recent round was a Seed of $6.6M in Oct 2025. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Epiminds is featured in
Similar companies
GlitchAds intends to democratize advertising by "leveraging" adverts and artificial intelligence.
Artificial Intelligence, Advertising Services, AI-Ad Generator, Effortless Ads, AI Ads
Omnia is an agentic platform that helps brands boost their presence across AI engines and assistants,
OMNIA which specializes in optimizing brand visibility in AI-powered search engines and assistants.
Garba AI is a business intelligence platform that delivers software to automate the sales process with AI-powered insights.
Kovant develops an AI agent platform to automate enterprise operations across supply chain, finance, and procurement.
AlixLabs provides nanostructure fabrication techniques through the use of the atomic layer etching process. This process is known for its ability to etch without causing damage. AlixLabs offers a method that relies on atomic layer etching to produce nanostructures with sizes smaller than 20 nm. Their technology surpasses the limitations of optical and electron beam lithography in creating nanostructures, making it valuable in the fabrication of nanoelectronic devices. Furthermore, this innovation has the potential to allow for cost-effective scaling of transistor channels in technology nodes below 20 nm.
AI sales assistant that eliminates administrative work for revenue teams
DREV offers innovative cleaning technology for battery manufacturing.
Grasp is a platform powered by artificial intelligence that has been developed to gather and analyze data on global businesses in order to offer market insights.
Cellcolabs is a biotechnology company that production of mesenchymal stromal cells for research and clinical applications.
Legora is an AI tool designed to assist lawyers in reviewing documents, conducting research, and creating legal materials. It aims to enhance productivity by automating routine tasks and improving workflow efficiency. Legora works closely with clients from initial contact to full implementation, ensuring that its solutions meet client needs and are embraced by all levels of staff within organizations.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.